Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung

Cancer Science

Volumn 98, Issue 11, 2007, Pages 1714-1719

  Fukui, Tomoya ^a,c   Tsuta, Koji ^a   Furuta, Koh ^a   Watanabe, Shun ichi ^a   Asamura, Hisao ^a   Ohe, Yuichiro ^a   Maeshima, Akiko Miyagi ^b   Shibata, Tatsuhiro ^b   Masuda, Noriyuki ^c   Matsuno, Yoshihiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MICRODISSECTION; MISSENSE MUTATION; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; CARCINOMA, SMALL CELL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34748863599     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00600.x     Document Type: Article

References (31)

1. Stupp R, Monnerat C, Turrisi AT 3rd, Perry MC, Leyvraz S. Small cell lung cancer: State of the art and feature perspectives. Lung Cancer 2004; 45: 105-17.
2. Chua YJ, Steer C, Yip D. Recent advances in management of small-cell lung cancer. Cancer Treat Rev 2004; 30: 521-43.
3. Aisner J. Extensive-disease small-cell lung cancer: The thrill of victory, the agony of defeat. J Clin Oncol 1996; 14: 658-65.
4. Simon GR, Wagner H. Small cell lung cancer. Chest 2003; 123: 259S-71S.
5. Travis WD, Coby TV, Corrin B, Shimosato Y, Brambilla E. World Health Organization International Histological Classification of Tumours; Histological Typing of Lung and Pleural Tumours, 3rd edn. Berlin: Springer, 1999.
6. Fraire AE, Johnson EH, Yesner R, Zhang XB, Spjut HJ, Greenberg SD. Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 1992;23: 520-8.
7. Mangum MD, Greco FA, Hainsworth JD, Hande KR, Johnson DH. Combined small-cell and non-small-cell lung cancer. J Clin Oncol 1989; 7: 607-12.
8. Hage R, Elbers JR, Brutel de la Riviere A, van den Bosch JM. Surgery for combined type small cell lung carcinoma. Thorax 1998; 53: 450-3.
9. Nicholson SA, Beasley MB, Brambilla E et al. Small cell lung carcinoma (SCLC): A clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002; 26: 1184-97.
10. Lucchi M, Mussi A, Chella A et al. Surgery in the management of small cell lung cancer. Eur J Cardiothorac Surg 1997; 12: 689-93.
11. de Antonio DG, Alfageme F, Gamez P, Cordoba M, Varela A. Results of surgery in small cell carcinoma of the lung. Lung Cancer 2006; 52: 299-304.
12. Deslauriers J. Surgery for small cell lung cancer. Lung Cancer 1997; 17: S91-8.
13. Ozanne B, Richards CS, Hendler F, Burns D, Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol 1986; 149: 9-14.
14. Cerny T, Barnes DM, Hasleton P et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer 1986; 54: 265-9.
15. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-39.
16. Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-500.
17. Takano T, Ohe Y, Sakamoto H et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005; 23: 6829-37.
18. Pao W, Miller VA. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 2005; 23: 2556-68.
19. Okamoto I, Araki J, Suto R, Shimada M, Nakagawa K, Fukuoka M. EGFR mutation in gefitinib-responsive small-cell lung cancer. Ann Oncol 2005; 17: 1028-9.
20. Zakowski MF, Ladanyi M, Kris MG. EGFR mutations in small-cell lung cancers in patients who have never smoked. N Engl J Med 2006; 355: 213-15.
21. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-17.
22. Evangelou E, Kyzas PA, Trikalinos TA. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 2005; 18:1490-7.
23. Nomoto K, Tsuta K, Takano T et al. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am J Clin Pathol 2006; 126: 608-15.
24. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science 1996; 274: 998-1001.
25. Araki J, Okamoto I, Suto R, Ichikawa Y, Sasaki J. Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer. Lung Cancer 2005; 48: 141-4.
26. Yoshida Y, Shibata T, Kokubu A et al. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005; 50: 1-8.
27. Blons H, Cote JF, Le Corre D et al. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation. Am J Surg Pathol 2006; 30: 1309-15.
28. Stahlman MT, Gray ME, Whitsett JA. Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J Histochem Cytochem 1996; 44: 673-8.
29. Jerome Marson V, Mazieres J, Groussard O et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004; 45: 125-34.
30. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 2006; 19: 1117-23.
31. Sturm N, Lantuejoul S, Laverriere MH et al. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 2001; 32: 918-25.